T1	Participants 378 478	Ninety-five primary insomniacs, 32-64 years old and 55 age- and sex-matched general population-based
T2	Participants 597 631	participants with primary insomnia
T3	Participants 986 996	insomniacs
T4	Participants 1164 1207	insomniacs with the highest screening MSLTs
T5	Participants 1409 1427	the zolpidem group
T6	Participants 1456 1473	the placebo group
T7	Participants 1589 1604	some insomniacs
